HOME >> MEDICINE >> NEWS
Scents will not rouse us from slumber, says new Brown University study

PROVIDENCE, R.I. -- While sound can disrupt sleep, scents cannot. People cannot rely on their sense of smell to awaken them to the danger of fire, according to a new Brown University study.

Study participants easily detected odors when awake and in the early transition into sleep (Stage One sleep) but, once asleep, did not. The findings indicate a significant alteration of perceptual processing as a function of sleep.

"Human olfaction appears insufficiently sensitive and reliable to act as a sentinel system," said Rachel S. Herz, visiting assistant professor of psychology and an author of a study titled "Minimal Olfactory Perception During Sleep: Why Odor Alarms Will Not Work for Humans," published in a recent issue of the journal Sleep.

Researchers studied the effects of two scents the pleasurable peppermint and offensive pyridine on six participants in their early 20s.

Over two nights, participants wore an elastic chinstrap to encourage nose breathing. Researchers presented odors through a tube attached to an air-dilution device. The odors were tested during moderately deep Stage Two sleep, deep Stage Four sleep and REM (rapid eye movement) sleep.

No one responded to peppermint during sleep. Responses to the intense and noxious pyridine were infrequent and did not wake any participants in the deepest stage of sleep. Pyridine is a component of coal tar and used as a herbicide for firewood, and thus a likely byproduct of many real fires, according to the authors.

However, sound woke the participants regardless of the sleep stage. A moderately loud auditory tone produced arousal from sleep virtually every time the scents did not.

Most odors stimulate people's trigeminal nerve to some degree, which is relevant to detection of the scent. Both odors used in the study were of comparable trigeminal strength even though one was pleasant and the other aversive at high concentrations.

"As the saying goes,"
'"/>

Contact: Kristen Cole
Kristen_Cole@brown.edu
401-863-7508
Brown University
17-May-2004


Page: 1 2

Related medicine news :

1. Scents and emotions linked by learning, Brown study shows
2. Brown and NIH create joint neuroscience graduate program
3. DHHS designates Brown as national site for Cochrane Collaboration
4. Brown researchers find new photoreceptor and visual system in the eye
5. Indiana University researchers closer to helping hearing-impaired using stem cells
6. Boston University team finds link between high cholesterol and better cognitive performance
7. University seeks recruits for arthritis study
8. University of Manchester awarded 826k for brain science and mental health research
9. $4 million grant boosts University of Michigan campaign for a new childrens hospital
10. Lead in the environment causes violent crime, reports University of Pittsburgh researcher at AAAS
11. Next generation body scanner launched by the University of Manchester

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Scents will not rouse from slumber says new Brown University study

(Date:4/17/2014)... signs of chronic inflammation in non-cancerous prostate tissue may ... cancer than those with no inflammation, according to results ... Johns Hopkins Kimmel Cancer Center. , The link between ... with so-called high-grade prostate cancer those with a ... presence of the most aggressive and rapidly growing prostate ...
(Date:4/17/2014)... a study published today in PLOS Pathogens , ... malaria is common can mount an immune response to ... avoid repeated bouts of high fever and illness and ... bloodstream. The findings may help researchers develop future interventions ... malaria parasite. , Each year, approximately 200 million cases ...
(Date:4/17/2014)... In a review published in the April issue of ... The Feinstein Institute for Medical Research, says it,s time ... approach to treating sepsis, which kills millions ... Sepsis occurs when molecules released into the bloodstream to ... body. Inflammation is necessary for maintaining good health ...
(Date:4/17/2014)... Doctors who treat patients with a severe and ... an agonizing treatment decision. , The drug sirolimus ... relieve shortness of breath. But some patients eventually ... potentially fatal complications following transplantation. , "It,s a ... director of Loyola University Medical Center,s LAM Clinic ...
(Date:4/17/2014)... By discovering a new mechanism that allows blood to ... UC Irvine and the Salk Institute have opened the ... stroke-induced brain damage. , A complex and devastating neurological ... primary reason for disability in the U.S. The blood-brain ... blood-borne material into the brain, causing the permanent deficits ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Study IDs new cause of brain bleeding immediately after stroke 2
(Date:1/15/2014)...  Zafgen, Inc., a leading biopharmaceutical company dedicated to ... today announced initial results from its Phase 2a ... aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome ... results showed improvements in body weight, hunger-related behaviors, ...
(Date:1/14/2014)... 2014 HeartWare International, Inc . (NASDAQ: ... miniaturized circulatory support technologies that are revolutionizing the treatment ... revenues for the fourth quarter of 2013 will be ... approximately $208 million. "Our full-year revenue growth ...
(Date:1/14/2014)... 14, 2014 InformEx, North America,s ... chemistry, will hold the 30 th edition of its ... Convention Center from January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ... pharmaceutical, fine chemical and specialty chemical companies will take part ...
Breaking Medicine Technology:Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: